About this trial
The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.
Eligibility criteria
Qualifiers
Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
premature children (born at less than 28 weeks gestational age).
Parent or legal guardian will also be enrolled as a participant
Parents must be English-speaking (able to provide consent and complete questionnaires).
Disqualifiers
Not suitable for study participation due to other reasons at the discretion of the investigator.
Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.
For parents or legal guardians, there are no exclusion criteria.
Trial design
Treatments tested in this trial
- Abecedarian Approach